title: Possible explanations for the antagonism by nicotine against reserpine-induced depletion of monoamines in mouse brain.
abstract: The inhibitory effect of nicotine pretreatment on reserpine-induced depletion of monoamines in mouse brain was investigated. The depletion of brain monoamines by 24 h after intraperitoneal injection of reserpine (2 mg/kg) was dose-dependently inhibited by nicotine (0.3-10 mg/kg, s.c.) pretreatment 20 min before reserpine injection. This effect of nicotine was more marked on dopamine depletion than on noradrenaline or 5-hydroxytryptamine depletion. The nicotine pretreatment also inhibited the reserpine-induced hypothermia and decrease in the locomotor activity. When reserpine (2 mg/kg) was injected intraperitoneally, the inhibitory effect of nicotine (3 mg/kg, s.c.) on the reserpine-induced depletion of brain monoamines and heart noradrenaline was not antagonized by hexamethonium (8 mg/kg, s.c.) but rather potentiated by mecamylamine (2 mg/kg, s.c.). However, when reserpine (0.5 mg/kg) was injected intravenously, pretreatment with nicotine (3 mg/kg, s.c.) inhibited the reserpine-induced dopamine depletion only, and this effect of nicotine was completely blocked by mecamylamine but not by hexamethonium. These results suggest that inhibitory effect of nicotine on the intraperitoneal reserpine-induced depletion of brain monoamines is due to an inhibition of absorption of reserpine, and that central nicotinic action is also involved in the antagonism by nicotine of reserpine-induced dopamine depletion.
authors.affiliation: Department of Pharmacology, Okayama University Medical School, Japan.
authors.forename: R
authors.initials: R
authors.lastname: Oishi
authors.forename: K
authors.initials: K
authors.lastname: Suemaru
authors.forename: K
authors.initials: K
authors.lastname: Furuno
authors.forename: Y
authors.initials: Y
authors.lastname: Gomita
authors.forename: K
authors.initials: K
authors.lastname: Saeki
mesh_terms: D000818:Animals; D015306:Biogenic Monoamines / Q000378:metabolism*; D001921:Brain / Q000187:drug effects* / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D006321:Heart / Q000187:drug effects; D007035:Hypothermia / Q000139:chemically induced / Q000517:prevention & control; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D009538:Nicotine / Q000494:pharmacology*; D011292:Premedication; D012110:Reserpine / Q000037:antagonists & inhibitors* / Q000494:pharmacology
chemical_list: D015306:Biogenic Monoamines; D009538:Nicotine; D012110:Reserpine